Raymond James Financial Services Advisors, Inc. Heron Therapeutics, Inc. Transaction History
Raymond James Financial Services Advisors, Inc.
- $73.5 Billion
- Q3 2024
A detailed history of Raymond James Financial Services Advisors, Inc. transactions in Heron Therapeutics, Inc. stock. As of the latest transaction made, Raymond James Financial Services Advisors, Inc. holds 55,595 shares of HRTX stock, worth $113,969. This represents 0.0% of its overall portfolio holdings.
Number of Shares
55,595
Previous 33,826
64.36%
Holding current value
$113,969
Previous $118,000
6.78%
% of portfolio
0.0%
Previous 0.0%
Shares
17 transactions
Others Institutions Holding HRTX
# of Institutions
173Shares Held
114MCall Options Held
2MPut Options Held
32.4K-
Rubric Capital Management LP New York, NY26.7MShares$54.8 Million0.68% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA8.5MShares$17.4 Million0.02% of portfolio
-
Black Rock Inc. New York, NY8.33MShares$17.1 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.16MShares$16.7 Million0.0% of portfolio
-
Velan Capital Investment Management LP Alpharetta, GA6.99MShares$14.3 Million22.07% of portfolio
About HERON THERAPEUTICS, INC.
- Ticker HRTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 118,774,000
- Market Cap $243M
- Description
- Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...